Oklahoma. Contact Information. Office: Fax: Statistics
|
|
- Sylvia Griffin
- 6 years ago
- Views:
Transcription
1 PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Vogt, Don - PMP Program Manager 419 NE 38th Terrace Oklahoma City OK Office: (405) Fax: (405) dvogt@obn.state.ok.us ASAP Versions Accepted ASAP 1995 ASAP 1997 ASAP 3/2005 Oklahoma Bureau of Narcotics Law Enforcement Agency Oklahoma pmphelpdesk@obn.state.ok.us ASAP 4/2007 ASAP 4-1/2010 ASAP 4-2/2011 Pharmacy in-state Pharmacy out-state/mail order Pharmacy out-state other Dispensing doctor Contact Information Office: Fax: Technological Capabilities Electronic data transmissio Fax data transmission Mail data transmission Media data transmission Required Data Transmitters Veterinarian Veterans Administration Indian Health Services Data Collection Entity: In-House Vendor name: In-House Data Storage Entity: In-House Vendor name: In-House Report Generation Entity: In-House Data Access Method: Web Portal/On-Line Statistics Vendor name: In-House Data Transmission Methods Allowed Other data transmission Other: Data Collection, Storage, Generation and Access Data Access Entity: In-House Vendor name: In-House PDMP region: Statistics Year: 2014 DEA Registered Prescribers: 15,868 State population: 3,878,051 DEA Registered Dispensers: 938 South
2 Interstate data sharing PMPi Hub RxCheck Hub RxSentry Hub HIE method Other Hub Data Access via Health Information Exchang via Electronic Health Recor via Pharmacy Dispensing Syste Controlled Schedules Monitored Schedule II monitored Schedule III monitored Schedule IV monitored Schedule V monitored Data Collection and Dates Collection frequency: 0 Legislation enacted: PDMP operational 1991 Data Sharing List of states involved in sharing: AR, KS Impediments to data sharing: Exact Match Probablistic Match Policies and Procedures Monitor other authority Remove from Monitoring Web 24/7 Fax 24/7 Web Business Hours Fax Business Hours Other Patient Matching Other Substances Monitored Probablistic/Manual Matc Other Match for queries Data Request Methods and Hours of Operation Phone Business Hours Business Hours Mail Business Hours In-Person Business Hours Other Relevant Statutes and Rules Law/Rule Website: Law/Statute citation: OK Statute Title ; Title ; 2-302; 2-309A to -309H; Regulation/Rule citation: OK Admin Regs 475: to -6 Dr Shopper law/statute: Pill Mill law/statute: Pain Clinic law/statute: Disclosure law/statute: OK Statute Title D Data Retention Policy All Information Purged Data Retention Time: Prescriber Information Purged Dispenser Information Purged Permanent Patient Information Purged Drug Information Purged Record Retention Details: 3 years of data kept on-line; older data is archived indefinitely. De-Identified Data Retention Details: Data Retention Retain De-Identified Data
3 Required Enrollment - Prescriber Required Enrollment - Dispenser PDMP Required Enrollment and Patient Query Required Patient Query - Prescriber Required Patient Query - Dispenser Required Patient Query Details: Beginning November 1, 2010, each registrant that prescribes, administers or dispenses methadone shall be required to check the prescription profile of the patient on the central repository of the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control Select Data Fields Available Payment method captured Patient Identification captured Person dropping off captured Person picking up captured Ability to id prescriber specialty Prescriber: Dispenser: Miscellaneous Capabilities and Policies Authority to release de-identified data Ability to de-identified data Authority to release for epidemiological or educational purposes Engaged in release for epidemiological or educational purposes Required Notification to consumers Mandated Use of Advisory Group Patient Access to Query List Requirements to Query PDMP must be registrants of the Oklahoma Bureau of Narcotics which is the dispensing authority for the state. Provide DEA Registration number and OBN registration number. must be registrants of the Oklahoma Bureau of Narcotics which is the dispensing authority for the state. Provide NCPDP number and OBN registration number. Regulatory Board: must request access on their department letterhead and be approved by OBN s director. Law Enforcement: must request access on their department letterhead and be approved by OBN s director. Provide ORI number Attorney General: Researcher: Patient: Other: Prescriber Access to Patient History Prescriber Access to Own History Dispenser Access to Patient History Dispenser Access to Own History PDMP Available Reports Available Reports to Selected Requestors Licensing Board Access to Patient History Licensing Board Access to Licensee History Law Enforcement Access to Patient History Law Enforcement Access to Prescriber History Law Enforcement Access to Dispenser History
4 Requestors and Reports Authorized to Generate Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Health Care Authority Designated legal, communications, an Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State
5 Requestors and Reports Being Generated Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Health Care Authority Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State
Tennessee. Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Tennessee Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board http://tn.gov/health/topic/csmd-board csmd.admin@tn.gov
More informationPuerto Rico. Contact Information. State Registrant Totals and Population. PDMP name: PR PDMP
Statistics website: Rodriguez, Cieni - Program Manager Carr. No. 2 Km 8.2, Bo. Juan Sanchez Bayamon, PR 00960 Office: (787) 763-7575 Fax: (787) 763-3152 Email: cieni.rodriguez@assmca.pr.gov Puerto Rico
More informationNew Mexico. Contact Information. State Registrant Totals and Population. PDMP name: NM PMP
Statistics website: Ryba, Peter, PharmD - PMP Director 5500 San Antonio Drive NE, Suite C Albuquerque NM 87109 Office: (505) 222-9818 Fax: (505) 222-9845 Email: peter.ryba@state.nm.us New Mexico PDMP name:
More informationKentucky. Kentucky Cabinet for Health and Family Services Office of Inspector General
PDMP name: Agency responsible: Agency type: PDMP email: PDMP website: Enrollment website: Query website: Data upload website: Statistics website: Kentucky Kentucky Cabinet for Health and Family Services
More informationAlaska. Contact Information. State Registrant Totals and Population. PDMP name: AKPDMP
Statistics website: Carrillo, Laura - PDMP Manager 550 W. 7th Ave, Ste 1500 Anchorage AK 99501 Office: (907) 269-8404 Fax: (907) 465-2974 Email: laura.carrillo@alaska.gov Alaska PDMP name: AKPDMP PDMP
More informationMassachusetts. Contact Information. State Registrant Totals and Population. PDMP name: MA Prescription Monitoring Program
Massachusetts PDMP name: MA Prescription Monitoring Program PDMP region: Agency responsible: Department of Public Health Agency type: Department of Health PDMP email: mapmp.dph@massmail.state.ma.us PDMP
More informationNevada. Contact Information. State Registrant Totals and Population
Statistics website: Long, Yenh - Program Administrator 431 W Plumb Ln Reno NV 89509 Office: (775) 687-5694 Fax: (775) 687-5161 Email: ylong@pharmacy.nv.gov Nevada PDMP name: Prescription Controlled Substance
More informationMississippi. Contact Information. State Registrant Totals and Population
Statistics website: Mueller, Stephanie - PMP Director 6360 I-55 North, Suite 400 Jackson, MS 39211 Office: (601) 899-0138 Fax: (601) 899-8904 Email: smueller@mbp.ms.gov Mississippi PDMP name: MS PMP Agency
More informationColorado. Contact Information
Colorado PDMP name: Prescription Drug Monitoring Program PDMP region: Agency responsible: Colorado State Board of Pharmacy Agency type: Pharmacy Board PDMP email: pdmpinqr@state.co.us PDMP website: https://www.colorado.gov/pacific/dora/pdmp
More informationMichigan. Contact Information. State Registrant Totals and Population. PDMP name: MAPS
Michigan PDMP name: MAPS PDMP region: Agency responsible: Bureau of Professional Licensing, Drug Monitoring Section Agency type: Professional Licensing Agency PDMP email: BPL-MAPS@michigan.gov PDMP website:
More informationNorth Carolina. Contact Information. State Registrant Totals and Population. PDMP region: PDMP name: Agency responsible:
PDMP name: Agency responsible: Agency type: PDMP email: PDMP website: Enrollment website: Query website: Data upload website: Statistics website: North Carolina PDMP region: South North Carolina Department
More informationTennessee. Contact Information. State Registrant Totals and Population. PDMP name: CSMD
Statistics website: Bess, D. Todd - Director, CSMD Program 665 Mainstream Drive Nashville TN 37243 Office: (615) 253-1305 Fax: Email: david.bess@tn.gov Tennessee PDMP name: CSMD PDMP region: South Agency
More informationOhio. Contact Information. State Registrant Totals and Population
PDMP name: OARRS Agency responsible: State of Ohio Board of Pharmacy Agency type: Pharmacy Board PDMP email: info@pharmacy.ohio.gov PDMP website: www.ohiopmp.gov Enrollment website: https://ohio.pmpaware.net
More informationTechnical Assistance Guide. Enhancing PDMPs: A Comparison of Changes 2010 to 2016
Technical Assistance Guide Enhancing PDMPs: A Comparison of Changes 2010 to 2016 December 2016 This project was supported by Grant No. 2014-PM-BX-K001 awarded by the Bureau of Justice Assistance. The Bureau
More informationPrescription Monitoring Programs - Legislative Trends and Model Law Revision
Prescription Drug Monitoring Programs Training and Technical Assistance Center Webinar Series National Alliance for Model State Drug Laws: Legislative Round-Up July 22, 2015 Prescription Monitoring Programs
More information2017 ASAP MIDYEAR CONFERENCE THE FUTURE OF PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): HIGHLIGHTS OF 2017 STATE BILLS JUNE 22, 2017 SHERRY L.
2017 ASAP MIDYEAR CONFERENCE THE FUTURE OF PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): HIGHLIGHTS OF 2017 STATE BILLS JUNE 22, 2017 SHERRY L. GREEN Disclosures Sherry Green is an employee of Na2onal
More informationPrescription Monitoring Program State Profiles - Michigan
Prescription Monitoring Program State Profiles - Michigan Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationPrescription Monitoring Program:
Massachusetts Department of Public Health Prescription Monitoring Program: The Massachusetts Prescription Monitoring Tool (MassPAT) November 1, 2016 Goals of the Session Understand the mission and responsibilities
More informationPrescription Monitoring Program State Profiles - California
Prescription Monitoring Program State Profiles - California Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More informationDistrict of Columbia Prescription Drug Monitoring Program
District of Columbia Prescription Drug Monitoring Program What Our Users Need to Know Health Regulation and Licensing Administration Pharmaceutical Control Division February 28, 2017 1 Mission Statement
More informationPrescription Monitoring Program State Profiles - Illinois
Prescription Monitoring Program State Profiles - Illinois Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationNCPDP s Recommendations for an Integrated, Interoperable Solution to Ensure Patient Safe Use of Controlled Substances
National Council for Prescription Drug Programs White Paper NCPDP s Recommendations for an Integrated, Interoperable Solution to Ensure Patient Safe Use of This white paper details a plan to nationally
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) West Virginia Information contained in this presentation is accurate as of October 2017 What is a Prescription Drug Monitoring Program? A PDMP/PMP is a statewide
More informationNATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT
1 NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the
More informationSTATE OF TEXAS TEXAS STATE BOARD OF PHARMACY
STATE OF TEXAS TEXAS STATE BOARD OF PHARMACY REQUEST FOR INFORMATION NO. 515-15-0002 PRESCRIPTION DRUG MONITORING PROGRAM Reference: CLASS: 920 ITEM: 05 Posting Date: 12/08/2014 RESPONSE DEADLINE: 01/05/2015
More informationOREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS
OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS DIVISION 121 PHARMACEUTICAL SERVICES Non-Medicaid Rules Prescription Drug Monitoring Program 410-121-4000 Purpose The purpose of the Prescription
More informationPrescription Drug Monitoring Program (PDMP) LOUISIANA. Information contained in this presentation is accurate as of September 2017
Prescription Drug Monitoring Program (PDMP) LOUISIANA Information contained in this presentation is accurate as of September 2017 Meet the Speaker Julie W. Breithaupt PharmD, MBA President Louisiana Pharmacists
More informationPMIX ADVANCING PMP DATA SHARING THROUGH STANDARDIZATION AND INNOVATION CARL FLANSBAUM, DIRECTOR, NEW MEXICO PMP CO-CHAIR PMIX WORKING GROUP
PMIX ADVANCING PMP DATA SHARING THROUGH STANDARDIZATION AND INNOVATION CARL FLANSBAUM, DIRECTOR, NEW MEXICO PMP CO-CHAIR PMIX WORKING GROUP PMIX: Past, Current and Future A PMIX Primer What is PMIX? Original
More informationPrescription Monitoring Program State Profiles - Pennsylvania
Prescription Monitoring Program State Profiles - Pennsylvania Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More informationPrescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness
Prescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness Peter Kreiner, Ph.D. Prescription Monitoring Program Center of Excellence at Brandeis University NGA Meeting September
More informationPRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE
PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationInterim Commissioner Lauren A. Smith and Members of the Public Health Council
DEVAL L. PATRICK GOVERNOR TIMOTHY P. MURRAY LIEUTENANT GOVERNOR JOHN W. POLANOWICZ SECRETARY LAUREN A. SMITH, MD, MPH INTERIM COMMISSIONER The Commonwealth of Massachusetts Executive Office of Health and
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New York State Information contained in this presentation is accurate as of September 2017 Meet the Speaker Anita Murray, R.Ph., Deputy Director Bureau of Narcotic
More informationGeorgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018
Georgia DPH Prescription Title Drug Heading Monitoring Program Program Sheila Pierce April 2018 What is the PDMP? Legislative Mandates Registration Requirements How to use the PDMP Next Steps for Prescribers
More informationStates that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New Jersey Information contained in this presentation is accurate as of September 2017 Meet the Speaker Sindy Paul, MD, MPH, FACPM Medical Director - NJ Board
More informationMassachusetts Prescription Monitoring Program
Massachusetts Prescription Monitoring Program PDMP Training and Technical Assistance Center at Brandeis University in partnership with the Bureau of Justice Assistance August 8, 2012 Massachusetts Department
More informationPRESCRIPTION MONITORING PROGRAM STATE PROFILES MASSACHUSETTS
PRESCRIPTION MONITORING PROGRAM STATE PROFILES MASSACHUSETTS Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationBJA COAP Category 5 Grantee Webinar Thursday, June 21, 2018
BJA COAP Category 5 Grantee Webinar Thursday, June 21, 2018 BJA Update Tara Kunkel Senior Drug Policy Advisor IPA Bureau of Justice Assistance U.S. Department of Justice BJA Grant Project Update: Washington
More informationMedication Assisted Treatment for Opioid Use Disorders Reporting Requirements
This document is scheduled to be published in the Federal Register on 09/27/2016 and available online at https://federalregister.gov/d/2016-23277, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES
More informationStates that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of
More informationThe Wisconsin epdmp:
The Wisconsin epdmp: Frequently Asked Questions Pursuant to 2015 Wisconsin Act 266, effective April 1, 2017, Wisconsin-licensed physicians and other prescribers must review a patient s records from Wisconsin
More informationMINNESOTA BOARD OF PHARMACY
MINNESOTA BOARD OF PHARMACY Prescription Drug Waste Reduction Report. (In compliance with Minnesota Session Laws, 2010 First Special Session, Chapter 1, section 21) Cody Wiberg, Pharm.D., M.S., R.Ph. Executive
More informationPrescription Monitoring Program State Profiles - Texas
Prescription Monitoring Program State Profiles - Texas Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationLegal Issues in Managing Opioid Abuse. Gwen Dayton, JD
Legal Issues in Managing Opioid Abuse Gwen Dayton, JD Faculty Disclosure It is the policy of the Oregon Hospice Association to insure balance, independence, objectivity, and scientific rigor in all its
More informationNEW MEXICO PRACTITIONER S MANUAL
NEW MEXICO PRACTITIONER S MANUAL An Informational Outline From the New Mexico Board of Pharmacy 5200 Oakland NE Suite A Albuquerque, New Mexico 87113 505-222-9830 800-565-9102 E-Mail: Debra.wilhite@state.nm.us
More informationDelegator Dashboard User Guide
Delegator Dashboard User Guide ULP Delegator Dashboard Technical Guide This guide is intended for a Prescriber or Pharmacist who is utilizing Delegates to facilitate PDMP data access. A separate guide
More informationSENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED APRIL 28, 2014
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED APRIL, 0 Sponsored by: Senator LORETTA WEINBERG District (Bergen) Senator JOSEPH F. VITALE District (Middlesex) Senator JAMES W. HOLZAPFEL District
More informationPrescription Monitoring Program State Profiles - Kentucky
Prescription Monitoring Program State Profiles - Kentucky Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationReport of the Task Force on Prescription Monitoring Program Standards
Report of the Task Force on Prescription Monitoring Program Standards Members Present: Gay Dodson (TX), chairperson; John Dorvee (ME); Danna Droz (OH); Allen F. Dulwick (OR); William Fitzpatrick (MO);
More informationSTATE STATUTORY AND REGULATORY LIMITS: DIRECT DISPENSING OF CONTROLLED SUBSTANCES BY PRACTITIONERS TO ULTIMATE USERS
STATE STATUTORY AND REGULATORY LIMITS: DIRECT DISPENSING OF CONTROLLED SUBSTANCES BY PRACTITIONERS TO ULTIMATE USERS Research current as of January 2014. Revised on March 28, 2014. This project was supported
More informationSteps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels. Nick Snyder, Esq.
Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels Nick Snyder, Esq. How Can We Impact Inappropriate Over-Prescribing of Opioids in Maine? What have other States or Organizations
More information2014 Complete Overview of the URAC Standards
2014 Complete Overview of the URAC Standards Session Code: TU09 Time: 10:00 a.m. 11:30 a.m. Total CE Credits: 1.5 Presented by: Sandra Greenwalt, RN, BSN, MCHA, CCM, CCP, CPHQ URAC Provider Credentialing,
More informationK-TRACS: Review of Program Data and a Qualitative Assessment Study
K-TRACS: Review of Program Data and a Qualitative Assessment Study Amy Curry, MD Clinical Assistant Professor University of Kansas School of Medicine - Wichita Department of Family and Community Medicine
More informationUnderstanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing
Understanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing Background As reported in the Spring 2009 issue of acpnews, ACP and Alberta Health and Wellness developed a new policy
More informationRole of e-prescribing in Preventing Opioid Abuse
Role of e-prescribing in Preventing Opioid Abuse John Klimek R.Ph. Senior Vice President Standards and Industry IT NCPDP March 16, 2017 Agenda Opioid Epidemic PDMP Benefits and Challenges Comprehensive
More informationTypes of Authorized Recipients Probation/Parole Officers or the Department of Corrections
Types of Authorized Recipients Probation/Parole Officers or the Department of Corrections Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office
More informationThe Challenges of Interstate Data Sharing
The Challenges of Interstate Data Sharing 2016 Harold Rogers Prescription Drug Monitoring Program National Meeting August 17 19, 2016 Background The Challenges of Interstate Data Sharing Prescription Monitoring
More informationMandatory Electronic Prescribing in NYS
Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting August 16-19, 2016 Anita Murray, R.Ph. Deputy Director NYS Department of Health Bureau of Narcotic Enforcement
More informationFrequently Asked Questions
1. What is dispensing? Frequently Asked Questions DO I NEED A PERMIT? Dispensing means the procedure which results in the receipt of a prescription drug by a patient. Dispensing includes: a. Interpretation
More informationEPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: March 2016
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: March 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 2 SENATE BILL 750* Health Care Committee Substitute Adopted 6/12/18
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 0 S SENATE BILL 0* Health Care Committee Substitute Adopted /1/ Short Title: Health-Local Confinement/Vet. Controlled Sub. (Public) Sponsors: Referred to: May,
More informationBold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing
Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing 700.001: Definitions Delegate means an authorized support staff
More informationRegulatory Agencies Impact on Health System Pharmacies
Regulatory Agencies Impact on Health System Pharmacies Winter 2006 Beverly Sheridan, RPh, JD Assistant Director, Harborview Pharmacy Affiliate Associate Professor, UW School of Pharmacy rower@u.washington.edu
More informationFlorida s New Law on Controlled Substance Prescribing
FLORIDA MEDICAL ASSOCIATION Florida s New Law on Controlled Substance Prescribing HB 21, signed into law by Gov. Rick Scott on March 19, 2018, imposes a number of legal requirements on healthcare practitioners
More informationAMENDMENT TO SENATE BILL 772. AMENDMENT NO.. Amend Senate Bill 772, AS AMENDED, by. replacing everything after the enacting clause with the following:
*LRB00RLC00a* Rep. Cynthia Soto Filed: //0 000SB0ham00 LRB0 0 RLC 00 a AMENDMENT TO SENATE BILL AMENDMENT NO.. Amend Senate Bill, AS AMENDED, by replacing everything after the enacting clause with the
More informationDC Board of Pharmacy and Pharmaceutical Control Update
DC Board of Pharmacy and Pharmaceutical Control Update Shauna K. White, Pharm.D, MS Executive Director Board of Pharmacy Program Manager - Pharmaceutical Control Division September 17, 2016 Objectives
More informationEvidence-Based Practices to Optimize Prescriber Use of PDMPs
Evidence-Based Practices to Optimize Prescriber Use of PDMPs Sheri Lawal, MPH, CHES Senior Associate, Substance Use Prevention and Treatment Initiative, The Pew Charitable Trusts Thomas Clark Research
More informationRULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION
RULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION CHAPTER 0800-02-25 WORKERS COMPENSATION MEDICAL TREATMENT TABLE OF CONTENTS 0800-02-25-.01 Purpose and Scope
More informationAnnual Report to the Prescription Drug Monitoring Program Advisory Commission
2015 Annual Report to the Prescription Drug Monitoring Program Advisory Commission PUBLIC HEALTH DIVISION Oregon Violent Death Reporting System Contents»» Acknowledgments... 1»» Executive summary... 2
More information10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure
Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial
More informationSummer Webinar Series. The Prescription Drug Monitoring Program (PDMP) Mandate and Where you Fit In June 21, 2018
1 Summer Webinar Series The Prescription Drug Monitoring Program (PDMP) Mandate and Where you Fit In June 21, 2018 2 Introductions Lindsey Ferris, MPH Program Director, HIE Projects PDMP Subject Matter
More informationFindings and Recommendations of the Prescription Monitoring Standards Workgroup
February 26, 2003 NATIONAL ASSOCIATION OF STATE CONTROLLED SUBSTANCES AUTHORITIES Katherine Keough, Executive Director 72 Brook Street, Quincy MA 02170 Tel: 617-472-0520 Fax: 617-472-0521 Findings and
More informationFrequently Asked Questions MN Prescription Monitoring Program (PMP)
Frequently Asked Questions MN Prescription Monitoring Program (PMP) Topics: 1. Purpose of the PMP 2. Reporting/Frequency of Reporting 3. Dispensing for Animals 4. Inappropriate Prescribing 5. Accessing
More informationMid-Atlantic Legislative/Regulatory June 2018 Update
Mid-Atlantic Legislative/Regulatory June 2018 Update Please Note: CCHP has a pending legislation/regulation webpage located at the following link: http://cchpca.org/state-laws-and-reimbursement-policies
More informationE Prescribing E Rx: Background. E Rx: Definition. Rebecca H. Wartman, O.D.
E Prescribing 2011 E Rx 2011 is presented by Rebecca H. Wartman, O.D. Practice Advancement Committee Member, Clinical and Practice Advancement Group American Optometric Association E Rx: Background Electronic
More informationPlease adjust your computer volume to a comfortable listening level. This is lesson 4 How do you handle medication at home?
Welcome to the Pennsylvania Department of Public Welfare (DPW), Office of Developmental Programs (ODP) Medication Administration Course for life sharers. This course was developed by the ODP Office of
More informationPrescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups
Prescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups Richard Deyo, MD, MPH Depts. of Family Medicine & Internal Medicine, Oregon Health & Science University Jessica Irvine, MS Acumentra
More informationHydrocodone Prescribing and the New Texas PMP
Hydrocodone Prescribing and the New Texas PMP MARC L. FLEMING, PHD, MPH, RPH ASSISTANT PROFESSOR, DEPARTMENT OF PHARMACEUTICAL HEALTH OUTCOMES & POLICY UNIVERSITY OF HOUSTON, COLLEGE OF PHARMACY Hydrocodone
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW SENATE BILL 750
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW 2018-76 SENATE BILL 750 AN ACT TO ADDRESS HEALTH ISSUES IN LOCAL CONFINEMENT FACILITIES AND TO ENSURE THAT STATE PRISONS ARE FULL PARTICIPANTS
More informationMedicare Advantage and Part D Fraud, Waste and Abuse Compliance Training 2015
Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training 2015 Overview This Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training for first-tier, downstream and related
More informationRequest for Information NJ Health Information Network. State of New Jersey. New Jersey HIT Coordinators Office. Request for Information
State of New Jersey New Jersey HIT Coordinators Office Request for Information New Jersey s Health Information Exchange The New Jersey Health Information Network (NJHIN) July 1, 2011 Page 1 of 11 Table
More informationNational Association of Boards of Pharmacy PMP Interconnect NABP
National Association of Boards of Pharmacy PMP Interconnect NABP Problems with PMPs: Persons engaging in doctor shopping don t stay in one state, particularly areas that border other states Querying the
More informationIssue Brief. E-Prescribing in California: Why Aren t We There Yet? Introduction. Current Status of E-Prescribing in California
E-Prescribing in California: Why Aren t We There Yet? Introduction Electronic prescribing (e-prescribing) refers to the computer-based generation of a prescription, electronic transmission of the initial
More informationMaking the Most of the Guide to Minnesota Class F Home
Making the Most of the Guide to Minnesota Class F Home Care Provider Rules Susan Christianson SDC Consulting Mhdmanor@cableone.net 218-236-6286 2/15/2010 1 Guide to Minnesota Class F Home Care Provider
More informationObjectives: Demonstration of MN PMP RxSentry Reports from workgroups
MN Prescription Monitoring Program Advisory Task Force Meeting Monday, September 29, 2014, 1:30pm-3:00pm University Park Plaza, 2829 University Ave SE, Conference Room A, Minneapolis, MN 55414 Objectives:
More informationTechnical Assistance Guide. Prescriber Report Cards
Technical Assistance Guide Prescriber Report Cards Revised February 17, 2017 This project was supported by Grant No. 2014-PM-BX-K001 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance
More informationStatement of Ronna B. Hauser, Pharm.D. Vice President, Policy and Regulatory Affairs National Community Pharmacists Association
Statement of Ronna B. Hauser, Pharm.D. Vice President, Policy and Regulatory Affairs National Community Pharmacists Association Food and Drug Administration [Docket Nos. FDA 2010 N 0284 and FDA 2009 D
More informationMARYLAND BOARD OF PHYSICIANS P.O. Box 2571 Baltimore, Maryland
MARYLAND BOARD OF PHYSICIANS P.O. Box 2571 Baltimore, Maryland 21215 www.mbp.state.md.us E-mail: mdh.mbppadispense@maryland.gov : ADDENDUM FOR PHYSICIAN ASSISTANT (PA) TO DISPENSE PRESCRIPTION DRUGS INSTRUCTIONS
More informationNCPDP Recommendations for Improving Prescription Drug Monitoring Programs
National Council for Prescription Drug Programs White NCPDP Recommendations for Improving Prescription Drug Monitoring Programs Version 2.0 May 2015 This white paper details a plan to nationally standardize
More informationPharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.
Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A. Objectives: Pharmacist and Pharmacy Technician Learning Objectives: At the end of this activity, participants
More informationTeaching Institution Application for Registration (Form DHHS 224-C)
Teaching Institution Application for Registration (Form DHHS 224-C) NC Department of Health and Human Services Division of Mental Health, Developmental Disabilities, and Substance Abuse Services Drug Control
More informationRULE THE PHYSICIAN S ROLE IN PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSES
DEPARTMENT OF REGULATORY AGENCIES Colorado Medical Board RULE 950 - THE PHYSICIAN S ROLE IN PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSES 3 CCR 713-37 [Editor s Notes follow the text of the rules
More informationMassachusetts Department of Public Health. Privacy of Health Data
Massachusetts Department of Public Health Privacy of Health Data Institutional Commitment to Privacy Privacy and Data Access Office Staffing Privacy Attorney Confidential Data Officer Admin Support Goals
More information2015 Annual Convention
2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 9:45 am 11:15 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 10 Title: Activity Type: Speaker: How to Be
More information(7) Indicate the appropriate and explicit directions for use. (9) Not authorize any refills for schedule II controlled substances.
ACTION: Revised DATE: 07/20/2017 4:25 PM 4729-5-30 Manner of issuance of a prescription. (A) A prescription, to be valid, must be issued for a legitimate medical purpose by an individual prescriber acting
More informationSession 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationPHARMACEUTICALS AND MEDICATIONS
DESCHUTES COUNTY ADULT JAIL CD-10-17 L. Shane Nelson, Sheriff Jail Operations Approved by: December 6, 2017 POLICY. PHARMACEUTICALS AND MEDICATIONS It is the policy of Deschutes County Sheriff s Office
More informationPayment: We are permitted to use and disclose your health information to receive payment for our services. For example, we may:
Your Rx Pharmacy Notice of our privacy practices THIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationCHI Mercy Health. Definitions
CHI Mercy Health Definitions If you have any questions about this notice, please contact the CHI Mercy Health s Privacy Office at (701) 845-6540 or 570 Chautauqua Blvd, Valley City ND 58072. Notice of
More information